amikacin has been researched along with cefuroxime in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (29.41) | 18.7374 |
| 1990's | 3 (8.82) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 7 (20.59) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| George, WL; Lewis, RP; Meyer, RD | 1 |
| Ball, P; Gray, J | 1 |
| Bartlett, M; Crane, JK; Griffin, PS; Miller, MA; Yousuf, M | 1 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Alvarez, S; DeMaria, A; Klein, JO; McCabe, WR | 1 |
| McVie, JG; Mullinger, BM; Stuart, JF | 1 |
| Desmond, AD; Hart, CA; Percival, A | 1 |
| Trollfors, B | 1 |
| Belohradsky, BH; Marget, W; Roos, R | 1 |
| Fota-Markowska, H; Hencner, Z; Jasińska, B; Szeniawska, A | 2 |
| Szmygin, K | 1 |
| Navarro, V; Roig, P; Salavert, M | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Kaczala, G; McDougall, J; Nelle, M; Slongo, T | 1 |
| Gelosa, L | 1 |
| Butler, L; Durrani, OM; Konstantinos, C; Mollan, AJ; Mollan, SP | 1 |
| Claxton, A; Erskine, K; Melendez, J | 1 |
| Fredrick, F; Massawe, A; Matee, MI; Mhada, TV | 1 |
| Agraharam, D; Chandra Mohan, AK; Jayaramaraju, D; Kulkarni, S; Perumal, R; Shanmuganathan, R | 1 |
| Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S | 1 |
| Altun, B; Cakar, A; Demirci-Duarte, S; Eser, OK; Gur, D; Sancak, B; Unalan-Altintop, T | 1 |
| Agarwal, M; Anand, AR; Biswas, J; Janani, MK; Patnaik, G; Sanghvi, K | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Avlami, A; Daikos, GL; Katsilambros, N; Kosmidis, C; Petrikkos, G; Psychogiou, M; Stefanou, I; Tassios, PT; Vasilakopoulou, A | 1 |
| Beceiro, A; Bou, G; Canle, D; Fernández, A; Lasa, I; Latasa, C; Mallo, S; Molina, F; Pérez, A; Pérez, S; Poza, M; Tomás, Mdel M; Villanueva, R | 1 |
| Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Albertí, S; Beceiro, A; Bou, G; Garau, M; Gutiérrez, O; Juan, C; Oliver, A; Pérez, JL | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Girlich, D; Nordmann, P; Poirel, L | 1 |
| Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for amikacin and cefuroxime
| Article | Year |
|---|---|
[Purulent pericarditis due to Salmonella enterica subsp. arizonae].
Topics: Amikacin; Animals; Animals, Domestic; Atrial Fibrillation; Cefuroxime; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Humans; Male; Middle Aged; Occupational Diseases; Occupational Exposure; Pericardiocentesis; Pericarditis; Salmonella arizonae; Salmonella Infections; Suppuration; Veterinary Medicine | 2002 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for amikacin and cefuroxime
| Article | Year |
|---|---|
Quantitative studies on antibiotic nephrotoxicity.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; beta 2-Microglobulin; Cefoxitin; Cefuroxime; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Glomerular Filtration Rate; Humans; Kidney Tubules, Proximal; Male; Middle Aged; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1980 |
31 other study(ies) available for amikacin and cefuroxime
| Article | Year |
|---|---|
Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae; Escherichia coli; Klebsiella; Penicillin Resistance; Piperacillin; Proteus; Pseudomonas aeruginosa; Serratia | 1978 |
Activity of cefuroxime, cefoxitin and amikacin against Serratia marcesens.
Topics: Amikacin; Cefoxitin; Cefuroxime; Cephalosporins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens | 1979 |
In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Serratia marcescens; Tobramycin | 1979 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Topics: Amikacin; Ampicillin; Carbenicillin; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Clindamycin; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Haemophilus influenzae; Moxalactam; Oxacillin | 1980 |
Treatment of cytotoxic drug-related infections.
Topics: Adult; Aged; Amikacin; Antineoplastic Agents; Bacteria; Bacterial Infections; Cefuroxime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged | 1983 |
Treatment of gentamicin-resistant Klebsiella urinary tract infections with cephradine, augmentin, cefuroxime and amikacin.
Topics: Adult; Aged; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Cephradine; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Combinations; Female; Gentamicins; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Urinary Tract Infections | 1981 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Meningitis; Sepsis; Tobramycin | 1980 |
[Investigations concerning the influence of cefuroxime and amikacin on dynamics of selected parameters of nonspecific cellular immunity in experimental animals].
Topics: Amikacin; Animals; Cefuroxime; Immunity, Cellular; Neutrophils; Phagocytosis; Rabbits | 1993 |
[Studies on the effect of cephradine, cefuroxime, lincomycin and amikacin on complement levels in experimental animals].
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefuroxime; Cephradine; Complement System Proteins; Lincomycin; Rabbits | 1993 |
[The influence of selected antibiotics on the central action of aminophyllines--experimental studies].
Topics: Amikacin; Aminophylline; Animals; Anti-Bacterial Agents; Cefuroxime; Convulsants; Doxycycline; Drug Interactions; Electroshock; Female; Mice; Penicillin G; Seizures | 1996 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Report of an uncommon cluster of septic arthritis of the hip in premature newborns: three cases in a period of 3 months.
Topics: Amikacin; Anti-Bacterial Agents; Arthritis, Infectious; Cefuroxime; Cross Infection; Disease Outbreaks; Diseases in Twins; Hip Joint; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Switzerland; Ultrasonography | 2005 |
Variations in sensitivity to antibiotics of staphylococci strains isolated from alimentary workers between 1985-1987.
Topics: Amikacin; Anti-Bacterial Agents; Cefazolin; Cefuroxime; Drug Resistance, Bacterial; Food Industry; Humans; Microbial Sensitivity Tests; Occupational Diseases; Staphylococcal Infections; Staphylococcus | 1989 |
Incidence of endophthalmitis following vitreoretinal surgery.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefuroxime; Endophthalmitis; Female; Gentamicins; Humans; Male; Middle Aged; Postoperative Complications; United Kingdom; Vancomycin; Visual Acuity; Vitrectomy; Vitreous Body | 2009 |
MRSA bacteraemia after caesarean section wound infection: when screening is missed and things go wrong.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cefuroxime; Cesarean Section; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Rifampin; Staphylococcal Infections; Teicoplanin; Trimethoprim; Wound Infection | 2012 |
Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome.
Topics: Amikacin; Ampicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cloxacillin; Escherichia coli; Female; Gentamicins; Humans; Infant, Newborn; Klebsiella; Male; Microbial Sensitivity Tests; Sepsis; Staphylococcus aureus; Tanzania; Treatment Outcome | 2012 |
Successful reimplantation of extruded long bone segments in open fractures of lower limb--a report of 3 cases.
Topics: Accidents, Traffic; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefuroxime; Debridement; Femoral Fractures; Fracture Healing; Fractures, Open; Humans; India; Male; Middle Aged; Replantation; Tibial Fractures; Treatment Outcome; Vancomycin | 2015 |
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli | 2015 |
Prevalence of O25b-ST131 clone and fosfomycin resistance in urinary Escherichia coli isolates and their relation to CTX-M determinant.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Urinary Tract Infections; Virulence Factors | 2020 |
Clinicopathological, Microbiological and Polymerase Chain Reaction Study in a Case of Nocardia Scleritis.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Cefuroxime; DNA, Bacterial; Drug Combinations; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Nocardia; Nocardia Infections; Polymerase Chain Reaction; Retrospective Studies; Scleritis; Slit Lamp Microscopy; Sulfamethoxazole; Trimethoprim; Visual Acuity | 2021 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.
Topics: Bacteremia; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Infectious Disease Transmission, Professional-to-Patient; Integrons; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Sequence Analysis, DNA; Treatment Outcome | 2007 |
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
Topics: Bacterial Proteins; Base Sequence; beta-Lactamases; Carrier Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, MDR; Genetic Vectors; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins | 2007 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Genes, Bacterial; Genetic Variation; Humans; Imipenem; Integrons; Kinetics; Meropenem; Molecular Sequence Data; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Homology, Amino Acid; Spain; Thienamycins | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |